NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 17 filers reported holding NOVUS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $0 | – | 591 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 591 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 591 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 591 | -85.3% | 0.00% | – |
| Q2 2019 | $4,000 | -78.9% | 4,027 | -15.2% | 0.00% | – |
| Q1 2019 | $19,000 | +1800.0% | 4,747 | +962.0% | 0.00% | – |
| Q4 2018 | $1,000 | -97.9% | 447 | -95.7% | 0.00% | – |
| Q3 2018 | $48,000 | -36.8% | 10,311 | -4.6% | 0.00% | – |
| Q2 2018 | $76,000 | – | 10,804 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 828,876 | $522,000 | 0.06% |
| 683 Capital Management, LLC | 623,102 | $386,000 | 0.04% |
| Orbimed Advisors | 3,183,314 | $1,974,000 | 0.04% |
| Boxer Capital, LLC | 324,383 | $201,000 | 0.02% |
| Hayden Royal, LLC | 10,000 | $6,000 | 0.01% |
| Virtu Financial LLC | 14,109 | $9,000 | 0.00% |
| VANGUARD GROUP INC | 62,761 | $39,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 2,110 | $1,000 | 0.00% |
| ROYAL BANK OF CANADA | 254 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |